This is a Healthcare Improvement Scotland (HIS) appraisal of the guidance issued by the National Institute for Health and Clinical Excellence.
This NICE appraisal has been considered by NHS Quality Improvement Scotland through its revised procedure of processing of NICE appraisals. NICE has said that HealOzone is not recommended as a treatment for specific types of tooth decay, unless it is being used in a clinical trial. The reason for this was that there was not enough reliable evidence that HealOzone is more effective than existing treatments for decay of the biting surfaces and roots of the teeth. No important differences were identified for this NICE appraisal, and NHS Quality Improvement Scotland advises that it is as valid for Scotland as for England and Wales.
NHSScotland should note that:
- No important differences were identified for this NICE appraisal, and NHS Quality Improvement Scotland advises that it is as valid for Scotland as for England and Wales.
- NHSScotland should take account of the NICE appraisal and this NHS Quality Improvement Scotland email in its planning, funding and provision of services to ensure that recommended drugs or treatments are made available to meet clinical need.
- NHS Quality Improvement Scotland advice represents the evidence-based view of NHS Quality Improvement Scotland.
- This advice does not override or replace the individual responsibility of health professionals to make appropriate decisions in the circumstances of their individual patients, in consultation with the patient and/or guardian or carer.
- No other publications on the NICE appraisal will be issued by NHS Quality Improvement Scotland.